Urolithin A & Heart Health: What the Science Suggests
The heart never rests, and to keep beating it relies on more mitochondria than almost any other tissue in the body. That is the biological reason urolithin A comes up in conversations about heart health — but the honest scientific picture is narrower and more careful than the headlines suggest.
The heart is a mitochondrial organ
Cardiac muscle cells are extraordinary energy consumers. To contract roughly 100,000 times a day without pause, they carry one of the highest mitochondrial densities of any cell type — mitochondria can occupy on the order of a third of a heart-muscle cell's volume, far more than in most tissues. The heart essentially cannot store much energy; it makes what it needs continuously, almost entirely through its mitochondria.
Because of that dependence, the quality of mitochondria matters to heart tissue. As mitochondria age they can become less efficient, and cells rely on a housekeeping process called mitophagy to identify, clear, and recycle worn-out mitochondria so healthier ones can take over. Mitophagy is the mechanism that connects urolithin A to any discussion of the heart — and it is important to understand exactly how far that connection has, and has not, been demonstrated in people.
What urolithin A is
Urolithin A is a postbiotic: a compound your gut bacteria produce when they break down ellagitannins, the polyphenols in pomegranates, walnuts, and certain berries. Not everyone's microbiome makes meaningful amounts, which is why a standardized supplement exists. Once absorbed, urolithin A has been shown to support mitophagy — the recycling of worn mitochondria. For the full background, see our complete urolithin A guide and our explainer on mitochondrial health.
Where the human evidence is genuinely strong
Let us be direct: the well-established human evidence for urolithin A is about mitochondrial and muscle function — not the cardiovascular system.
Published human trials
The first-in-human study, Andreux and colleagues in Nature Metabolism (2019), established that urolithin A was safe and well tolerated up to 1,000 mg per day and produced a mitochondrial gene-expression signature. In 2022, a randomized trial by Liu, D'Amico and colleagues in JAMA Network Open found improved muscle endurance in older adults over about four months. That same year, Singh and colleagues reported in Cell Reports Medicine that middle-aged adults taking 500 mg or 1,000 mg saw improvements in muscle strength and exercise performance. A 2025 randomized trial in Nature Aging found that roughly 28 days of supplementation supported the mitochondrial health of immune cells in midlife adults — relevant to the low-grade inflammation, or inflammaging, of aging. Additional 2024–2025 trials in resistance-trained men and in distance runners looked at endurance and recovery markers.
Notice the pattern: these controlled human studies measured skeletal muscle, exercise capacity, and immune-cell mitochondria. None of them measured blood pressure, cholesterol, cardiac output, or any cardiovascular outcome.
The heart-specific research is preclinical — what that means
The foundational study by Ryu and colleagues in Nature Medicine (2016) showed urolithin A induced mitophagy, extended lifespan in the worm C. elegans, and improved muscle function in rodents. It launched the entire field — and it is animal and cell research, not human proof. Building on that, early and preclinical research is exploring how supporting mitophagy might relate to heart tissue in laboratory and animal models, because damaged mitochondria are a feature of the aging and stressed heart.
This is a scientifically reasonable line of inquiry. But a result in a mouse heart or in cultured cells is a hypothesis to test in humans — not evidence that a supplement does anything for a person's cardiovascular health. To date there are no controlled human trials showing that urolithin A improves any cardiovascular outcome. A 2024 systematic review in Ageing Research Reviews summarized the whole field as still emerging, based on relatively short trials with modest sample sizes. That caution applies with particular force to the heart, where human outcome data simply do not yet exist.
A clear, non-negotiable note on the heart
Heart health is a serious, condition-adjacent area, and we will not blur the line. Urolithin A is a structure/function supplement that supports the body's mitochondrial housekeeping. It is not a treatment for high blood pressure, high cholesterol, heart failure, arrhythmia, coronary disease, or any cardiovascular condition, and it is not a substitute for medical care. It should never replace prescribed medication or delay proper evaluation.
If you have a heart condition, risk factors, or symptoms such as chest pain, shortness of breath, palpitations, or swelling, those require a doctor — not a supplement. And because polyphenol compounds can interact with certain medications, anyone taking blood thinners, blood-pressure medication, or other cardiac drugs should talk to their physician or pharmacist before adding urolithin A. This is not a treatment; see your doctor for anything involving your heart.
Setting realistic expectations
Even in the muscle studies where benefits were measured, the changes were meaningful but modest and took months of daily use to appear. Urolithin A supports gradual cellular processes; it is not a stimulant and will not produce a felt, next-day change. Framing it as broad mitochondrial support — the thing the human evidence actually addresses — is both accurate and the right way to decide whether it fits your goals. If you want realistic timelines, see how long urolithin A takes to work.
How SOMA HEALTH formulated it
SOMA HEALTH Urolithin A Gummies deliver 1,000 mg per four-gummy daily serving — the top of the clinically studied 500–1,000 mg range — with 120 gummies per bottle (a 30-day supply), a sugar-free raspberry format, and third-party testing on every batch. Being sugar-free matters to us: it would be inconsistent to talk about supporting cellular health while loading a gummy with added sugar. We chose the studied dose rather than a fractional "pixie-dust" amount so the product reflects what published human research actually used. For more, see our page on urolithin A dosage and our comparison of the best urolithin A gummies.
Practical guidance
If you choose to try urolithin A, take it daily and consistently, with or without food, the way the human trials dosed it. Support your mitochondria the boring, proven ways too — regular movement, strength work, sleep, and a plant-forward diet do more for heart and mitochondrial health than any single supplement. Keep your expectations tied to the evidence: mitochondrial and muscle support, not cardiovascular treatment. And if you have any heart concern or take cardiac medication, clear it with your doctor first.
Frequently asked questions
Does urolithin A lower blood pressure or cholesterol?
There is no controlled human trial showing urolithin A lowers blood pressure, cholesterol, or any cardiovascular marker. Human evidence covers muscle and mitochondrial function; heart-specific research is early and preclinical. Blood pressure and cholesterol should be managed with your doctor.
Is urolithin A good for the heart?
The heart is highly dependent on mitochondria, and urolithin A supports mitophagy, which is why the topic comes up. But the human evidence is for muscle and mitochondrial function, and heart-specific work is preclinical. We do not make cardiovascular claims.
Can I take it with my heart medication?
Ask your doctor or pharmacist first. Polyphenol compounds can interact with some medications, including blood thinners and blood-pressure drugs. Never add a supplement to a cardiac regimen without professional guidance, and never stop prescribed medication.
Is this a treatment for heart disease?
No. Urolithin A is a structure/function supplement, not a treatment for any disease. It is not intended to diagnose, treat, cure, or prevent any cardiovascular condition. See your doctor for anything involving your heart.
What dose was used in human studies?
Human trials used 500 mg to 1,000 mg per day. SOMA HEALTH Urolithin A Gummies provide 1,000 mg per daily serving, the top of that studied range.
How long before I might notice anything?
The human trials that measured benefits ran for roughly four months of daily use. Urolithin A supports gradual cellular processes, so consistency over months is the right expectation — and any benefits are about mitochondrial and muscle function, not cardiovascular outcomes.
Is it safe?
In the first-in-human study it was safe and well tolerated up to 1,000 mg per day. Even so, if you have a heart condition, take medications, or are pregnant or nursing, talk to your doctor before starting.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.
A clinically studied 1,000 mg dose of Urolithin A in one simple daily gummy — to support mitophagy, muscle strength, and cellular energy.
Shop SOMA Urolithin A Gummies →